Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tumor associated fibroblasts (TAF), are essential for tumor progression providing both a functional and structural supportive environment. TAF, known as activated fibroblasts, have an established biological impact on tumorigenesis as matrix synthesizing or matrix degrading cells, contractile cells, and even blood vessel associated cells. The production of growth factors, cytokines, chemokines, matrix-degrading enzymes, and immunomodulatory mechanisms by these cells augment tumor progression by providing a suitable environment. There are several suggested origins of the TAF including tissue-resident, circulating, and epithelial-to-mesenchymal-transitioned cells. METHODOLOGY/PRINCIPAL FINDINGS: We provide evidence that TAF are derived from mesenchymal stem cells (MSC) that acquire a TAF phenotype following exposure to or systemic recruitment into adenocarcinoma xenograft models including breast, pancreatic, and ovarian. We define the MSC derived TAF in a xenograft ovarian carcinoma model by the immunohistochemical presence of 1) fibroblast specific protein and fibroblast activated protein; 2) markers phenotypically associated with aggressiveness, including tenascin-c, thrombospondin-1, and stromelysin-1; 3) production of pro-tumorigenic growth factors including hepatocyte growth factor, epidermal growth factor, and interleukin-6; and 4) factors indicative of vascularization, including alpha-smooth muscle actin, desmin, and vascular endothelial growth factor. We demonstrate that under long-term tumor conditioning in vitro, MSC express TAF-like proteins. Additionally, human MSC but not murine MSC stimulated tumor growth primarily through the paracrine production of secreted IL6. CONCLUSIONS/SIGNIFICANCE: Our results suggest the dependence of in vitro Skov-3 tumor cell proliferation is due to the presence of tumor-stimulated MSC secreted IL6. The subsequent TAF phenotype arises from the MSC which ultimately promotes tumor growth through the contribution of microvascularization, stromal networks, and the production of tumor-stimulating paracrine factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Secretion of elevated levels of IL-6 by MSC has been detected upon interaction with malignant cells in several epithelial, hematopoietic and mesenchymal cancers (Table 2) [43, 69, 76, 77, 82, 115–119].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [82]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another mechanism that could increase the aggressiveness of a tumour is the potential differentiation of MSCs to tumour associated fibroblasts that are capable of increasing neovascularization within the tumour stroma and the metastatic rate [76], [77].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There they can potentiate further tumorigenesis via differentiation into tumor-nurturing stroma (TAF, myofibroblasts) [82, 104], direct cell contact interaction with cancer cells [105, 106] or release of paracrine factors (Table 2).”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Self-citationKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“The second characteristic is the degree of expression of the proteins of ‘‘aggression’’ such as SL-1, otherwise known as MMP3, a degradative enzyme highly expressed by fibroblasts [42] and utilized in tissue remodeling by TAF [21].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“The tropism of MSC for tumors is thought to be due to similarity in factors secreted by wounds and tumors [13], substantiating the concept that tumors are ‘‘wounds that never heal’’ [14,15].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206 · cited 1×
“[33].”
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043 · cited 1×
“Typically, the cells associated with the abnormal, tumorassociated, fibrovascular septa are not the archetypal vascular endothelial cells classified by factor VIII, CD31 and CD34, but instead are networks consisting of collagen and laminin subtypes in addition to activated fibroblasts and macrophages [45].”
BackgroundMesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro
Oswald, J., Boxberger, S., Jørgensen, B., Feldmann, S., Ehninger, G., Bornhäuser, M., & Werner, C. (2004) · STEM CELLS · doi:10.1634/stemcells.22-3-377 · Cited by 1,317 · cited 1×
“a-SMA positivity has been used previously to identify differentiated MSC [44].”
MethodDevelopment of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196 · cited 1×
“Skov-3 tumor cells were stably transduced using a lentivirus expressing red fluorescent protein and renilla luciferase (rLuc) [56,57].”
MethodHuman Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035 · cited 2×
“In those and subsequent studies, we demonstrated that MSC, administered intravenously, were able to integrate and persist within tumor stroma of pre-established human melanoma, breast cancer and glioma xenografts [11,12,16].”
BackgroundSelf-citationPeister, A., Mellad, J. A., Larson, B. L., Hall, B. M., Gibson, L. F., & Prockop, D. J. (2004) · Blood · doi:10.1182/blood-2003-09-3070 · Cited by 994 · cited 1×
“Murine MSC (mMSC) cell lines from C57/B6, balb/C were isolated as described previously [55] Fibroblast 3T3 cells and mMSC were cultured in alpha-MEM containing 20% FBS and 10% LPS.”
MethodSelf-citation(2002) · PubMed · Cited by 903
Self-citationStudeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 842 · cited 4×
“In those and subsequent studies, we demonstrated that MSC, administered intravenously, were able to integrate and persist within tumor stroma of pre-established human melanoma, breast cancer and glioma xenografts [11,12,16].”
BackgroundSelf-citationHuman mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747 · cited 1×
“MSC represent a relatively well-defined ex vivo cell population with complex and poorly understood biology in vivo [28], [29].”
BackgroundAntitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597 · cited 1×
“Recently, published data identify pericyte characteristics by α-SMA staining within an in vivo glioma tumor model of systemically injected MSC [26].”
BackgroundInflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells
Spaeth, E., Klopp, A., Dembinski, J., Andreeff, M., & Marini, F. (2008) · Gene Therapy · doi:10.1038/gt.2008.39 · Cited by 579 · cited 1×
“The tropism of MSC for tumors is thought to be due to similarity in factors secreted by wounds and tumors [13], substantiating the concept that tumors are ‘‘wounds that never heal’’ [14,15].”
BackgroundSelf-citationMesenchymal stem cells: paradoxes of passaging
Javazon, E. H., Beggs, K. J., & Flake, A. W. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.02.004 · Cited by 527 · cited 1×
“MSC represent a relatively well-defined ex vivo cell population with complex and poorly understood biology in vivo [28,29].”
BackgroundMigratory neighbors and distant invaders: tumor-associated niche cells
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 381 · cited 1×
“tumor-associated stromal cells as ‘‘migratory neighbors and distant invaders’’ [1].”
BackgroundStromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer
Tsujino, T., Seshimo, I., Yamamoto, H., Ngan, C. Y., Ezumi, K., Takemasa, I., Ikeda, M., Sekimoto, M., Matsuura, N., & Monden, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2191 · Cited by 352 · cited 1×
“The presence of fibroblast populations within human tumors is associated with poor outcome and an increase in metastatic potential [7,8].”
BackgroundKlopp, A. H., Spaeth, E. L., Dembinski, J. L., Woodward, W. A., Munshi, A., Meyn, R. E., Cox, J. D., Andreeff, M., & Marini, F. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1406 · Cited by 304 · cited 1×
“Skov-3 tumor cells were stably transduced using a lentivirus expressing red fluorescent protein and renilla luciferase (rLuc) [56,57].”
MethodSelf-citationScatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
Abounader, R., & Laterra, J. (2005) · Neuro-Oncology · doi:10.1215/s1152851705000050 · Cited by 300 · cited 1×
“The HGF/c-Met interaction plays a pivotal role in cancer invasion that is mediated by the tumor stromal cell production of HGF [52], which can induce ECM degradation, tubule formation and angiogenesis [53].”
BackgroundVEGF‐null cells require PDGFR α signaling‐mediated stromal fibroblast recruitment for tumorigenesis
Dong, J., Grunstein, J., Tejada, M., Peale, F., Frantz, G., Liang, W., Bai, W., Yu, L., Kowalski, J., Liang, X., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600289 · Cited by 295 · cited 1×
“Data in the literature currently support four origins: (1) the recruitment of resident tissue stem cells, (2) epithelial to mesenchymal transition of the tumor parenchyma, (3) fibroblast recruitment into the tumor stroma, and (4) recruitment of bone marrow-derived cells from the circulation [2–5].”
BackgroundHung, S.-C., Deng, W.-P., Yang, W. K., Liu, R.-S., Lee, C.-C., Su, T.-C., Lin, R.-J., Yang, D.-M., Chang, C.-W., Chen, W.-H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0876 · Cited by 268 · cited 1×
“These data were confirmed in other tumor models [31,32], most recently by Weinberg et al.”
ResultMesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
Sonabend, A. M., Ulasov, I. V., Tyler, M. A., Rivera, A. A., Mathis, J. M., & Lesniak, M. S. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0758 · Cited by 254
Bexell, D., Gunnarsson, S., Tormin, A., Darabi, A., Gisselsson, D., Roybon, L., Scheding, S., & Bengzon, J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.229 · Cited by 248 · cited 1×
“Recently, published data identify pericyte characteristics by a-SMA staining within an in vivo glioma tumor model of systemically injected MSC [26].”
BackgroundPECAM-1: old friend, new partners
Ilan, N., & Madri, J. A. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00100-5 · Cited by 236 · cited 1×
“Initial gene-expression profiles of long-term Skov-3—conditioned MSC reveal the upregulation of several laminin and collagen subtypes (data not shown); the deposition of these matrix proteins is associated with pre-vasculogenesis in preparation for the later stages including angiogenesis [46].”
BackgroundRegulation of Smooth Muscle Actin Expression and Contraction in Adult Human Mesenchymal Stem Cells
Kinner, B., Zaleskas, J. M., & Spector, M. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5561 · Cited by 232 · cited 1×
“Activated fibroblasts and myofibroblasts contribute to the formation of microvascular structures and can be detected by aSMA and desmin expression [24,25].”
BackgroundMelanoma–stroma interactions: structural and functional aspects
Ruiter, D., Bogenrieder, T., Elder, D., & Herlyn, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00620-9 · Cited by 231 · cited 1×
“Activated fibroblasts form fibrovascular stromal patterns, a diverse arrangement of septa within tumors; their presence represents disordered, rapid tumor growth and can be associated with heightened tumor aggressiveness and poor prognostic outcome [23].”
BackgroundInterleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer
Sasser, A. K., Sullivan, N. J., Studebaker, A. W., Hendey, L. F., Axel, A. E., & Hall, B. M. (2007) · The FASEB Journal · doi:10.1096/fj.07-8832com · Cited by 222
Self-citationDirect cell contact influences bone marrow mesenchymal stem cell fate
Ball, S. G., Shuttleworth, A. C., & Kielty, C. M. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.015 · Cited by 203 · cited 1×
“Activated fibroblasts and myofibroblasts contribute to the formation of microvascular structures and can be detected by aSMA and desmin expression [24,25].”
BackgroundHall, B., Andreeff, M., & Marini, F. (2007) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68976-8_12 · Cited by 194 · cited 3×
“The second characteristic is the degree of expression of the proteins of ‘‘aggression’’ such as SL-1, otherwise known as MMP3, a degradative enzyme highly expressed by fibroblasts [42] and utilized in tissue remodeling by TAF [21].”
BackgroundSelf-citationThe fibroblast: Sentinel cell and local immune modulator in tumor tissue
Silzle, T., Randolph, G. J., Kreutz, M., & Kunz‐Schughart, L. A. (2004) · International Journal of Cancer · doi:10.1002/ijc.11542 · Cited by 185 · cited 1×
“These TAF are associated with expression of factors involved in degradation of matrix proteins, angiogenesis and promotion of cell growth: matrix metalloproteinases (MMP), plasminogen activator inhibitor-1, vascular endothelial growth factor (VEGF), insulin growth factor (IGF-2) and hepatocyte growth factor (HGF) [9].”
BackgroundProfiling molecular targets of TGF-β1 in prostate fibroblast-to-myofibroblast transdifferentiation
Untergasser, G., Gander, R., Lilg, C., Lepperdinger, G., Plas, E., & Berger, P. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.023 · Cited by 182
Ohlsson, L. B., Varas, L., Kjellman, C., Edvardsen, K., & Lindvall, M. (2003) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2003.06.001 · Cited by 182 · cited 1×
“MSC represent a relatively well-defined ex vivo cell population with complex and poorly understood biology in vivo [28], [29].”
BackgroundMesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles
Hall, B., Dembinski, J., Sasser, A., Studeny, M., Andreeff, M., & Marini, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06230 · Cited by 171 · cited 1×
“The first is the bone marrow-derived progenitor population of which both hematopoietic stem cells [6] and MSC [12,21,22] are suggested as precursors; the second is a tissue-resident MSC population.”
BackgroundSelf-citationTargeted Delivery of CX3CL1 to Multiple Lung Tumors by Mesenchymal Stem Cells
Xin, H., Kanehira, M., Mizuguchi, H., Hayakawa, T., Kikuchi, T., Nukiwa, T., & Saijo, Y. (2007) · STEM CELLS · doi:10.1634/stemcells.2006-0461 · Cited by 164 · cited 1×
“It has been proposed that this tropism could be exploited by using MSC as gene-delivery vehicles for anticancer therapies, and this approach has shown promise in preclinical models [11,12,16–19].”
BackgroundJeon, E. S., Moon, H. J., Lee, M. J., Song, H. Y., Kim, Y. M., Cho, M., Suh, D.-S., Yoon, M.-S., Chang, C. L., Jung, J. S., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0742 · Cited by 161 · cited 1×
“MSC are pericytic precursors [27], and thus we hypothesize that they are precursors of TAF, which are identified by pericytic, myofibroblastic and ‘‘activated’’ fibroblastic markers.”
BackgroundKunz‐Schughart, L. A., & Knuechel, R. (2002) · PubMed · doi:10.14670/hh-17.599 · Cited by 161 · cited 3×
“TAF are characterized by the presence of four qualifying factors: (1) fibroblast markers fibroblast-specific protein (FSP) and fibroblast activating protein (FAP); (2) genes associated with an increase of tumor aggression, including stromelysin-1 (SL-1), thrombospondin-1 (Tsp-1) and tenascin-C (Tn-C); (3) myofibroblas…”
BackgroundJodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., Coussens, L. M., & DeClerck, Y. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3770 · Cited by 159 · cited 1×
“Data in the literature currently support four origins: (1) the recruitment of resident tissue stem cells, (2) epithelial to mesenchymal transition of the tumor parenchyma, (3) fibroblast recruitment into the tumor stroma, and (4) recruitment of bone marrow-derived cells from the circulation [2–5].”
BackgroundMolecular Repair, Wound Healing, And Carcinogenesis: Tumor Production A Possible Overhealing?
Haddow, A. (1973) · Advances in cancer research · doi:10.1016/s0065-230x(08)60341-3 · Cited by 158 · cited 1×
“The tropism of MSC for tumors is thought to be due to similarity in factors secreted by wounds and tumors [13], substantiating the concept that tumors are ‘‘wounds that never heal’’ [14,15].”
BackgroundTargeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells
Kanehira, M., Xin, H., Hoshino, K., Maemondo, M., Mizuguchi, H., Hayakawa, T., Matsumoto, K., Nakamura, T., Nukiwa, T., & Saijo, Y. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701079 · Cited by 156 · cited 1×
“It has been proposed that this tropism could be exploited by using MSC as gene-delivery vehicles for anticancer therapies, and this approach has shown promise in preclinical models [11,12,16–19].”
BackgroundHematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications
Ogawa, M., LaRue, A. C., & Drake, C. J. (2006) · Blood · doi:10.1182/blood-2006-04-016600 · Cited by 150 · cited 2×
“The first is the bone marrow-derived progenitor population of which both hematopoietic stem cells [6] and MSC [12,21,22] are suggested as precursors; the second is a tissue-resident MSC population.”
BackgroundCoevolution of cancer and stromal cellular responses
Littlepage, L. E., Egeblad, M., & Werb, Z. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.019 · Cited by 138 · cited 1×
“The first characteristic requires expression of two fibroblastic markers: FAP, which is expressed on MSC and fibroblasts [40] and FSP, a marker overexpressed in TAF as compared to normal fibroblasts [41].”
BackgroundSasser, A. K., Mundy-Bosse, B. L., Smith, K. M., Studebaker, A. W., Axel, A. E., Haidet, A. M., Fernández, S., & Hall, B. M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.012 · Cited by 136 · cited 4×
“In contrast to MSC inhibiting tumor progression and similar to what is described within this paper, our previous data shows that MSC can enhance the growth rate of a subpopulation of breast cancer cells in vitro and in vivo through paracrine interleukin-6 (IL-6) signaling events [38,39].”
BackgroundMethodResultSelf-citationSilencing the MET oncogene leads to regression of experimental tumors and metastases
Corso, S., Migliore, C., Ghiso, E., Rosa, G. D., Comoglio, P. M., & Giordano, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210697 · Cited by 129 · cited 12×
“Growth factors stain in patches that do not correlate with the more sparse staining patterns of the TAF markers themselves due to the fact that the tumor cells also secrete the growth factors HGF, IL-6 and EGF in the presence of MSC as demonstrated by in vitro co-culture data (Figure S4).”
BackgroundInfluentialSignificance of Tumor-Associated Stroma in Promotion of Intratumoral Lymphangiogenesis
Koyama, H., Kobayashi, N., Harada, M., Takeoka, M., Kawai, Y., Sano, K., Fujimori, M., Amano, J., Ohhashi, T., Kannagi, R., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070360 · Cited by 126 · cited 1×
“Data in the literature currently support four origins: (1) the recruitment of resident tissue stem cells, (2) epithelial to mesenchymal transition of the tumor parenchyma, (3) fibroblast recruitment into the tumor stroma, and (4) recruitment of bone marrow-derived cells from the circulation [2–5].”
BackgroundLabelle, M., Schnittler, H. J., Aust, D. E., Friedrich, K., Baretton, G., Vestweber, D., & Breier, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2706 · Cited by 111 · cited 1×
“However, in previous studies with altered tumor:MSC ratios, MSC have had adverse effects on tumor growth, prolonging the survival of the mice by hampering tumor proliferation (data not shown) [34]–[37].”
BackgroundLazarides, E., Granger, B. L., Gard, D. L., O'Connor, C. M., Breckler, J., Price, M. P., & Si, D. (1982) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1982.046.01.036 · Cited by 106 · cited 1×
“Desmin, a muscle-specific, intermediate filament protein common in myofibrils [43], was expressed in huMSC derived fibroblasts in a heterogeneous pattern of distribution.”
BackgroundYang, F., Strand, D. W., & Rowley, D. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210663 · Cited by 102 · cited 1×
“Several adenocarcinoma tumor-microenvironment crosstalk models implicate growth factors including HGF, [49] VEGF, [50] TGF-b, and FGF [51] in the promotion/progression of tumorigenesis.”
BackgroundAnnabi, B., Naud, E., Lee, Y., Eliopoulos, N., & Galipeau, J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10763 · Cited by 101
Yazhou, C., Wenlv, S., Zhang, W., & Wu, L. (2004) · Tumor Biology · doi:10.1159/000081394 · Cited by 98 · cited 1×
“The presence of fibroblast populations within human tumors is associated with poor outcome and an increase in metastatic potential [7,8].”
BackgroundFibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow
Bae, S., Park, C. W., Son, H. K., Ju, H. K., Paik, D., Jeon, C., Koh, G. Y., Kim, J., & Kim, H. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07241.x · Cited by 72 · cited 1×
“The first characteristic requires expression of two fibroblastic markers: FAP, which is expressed on MSC and fibroblasts [40] and FSP, a marker overexpressed in TAF as compared to normal fibroblasts [41].”
BackgroundSpix, J. K., Chay, E. Y., Block, E. R., & Klarlund, J. K. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.006 · Cited by 70 · cited 1×
“HGF also has the ability to transactivate the EGF receptor to induce motility [54] and reciprocally, EGF is able to stimulate HGF production [52].”
BackgroundUdagawa, T., Puder, M., Wood, M., Schaefer, B. C., & D'Amato, R. J. (2006) · The FASEB Journal · doi:10.1096/fj.04-3669com · Cited by 69 · cited 1×
“Data in the literature currently support four origins: (1) the recruitment of resident tissue stem cells, (2) epithelial to mesenchymal transition of the tumor parenchyma, (3) fibroblast recruitment into the tumor stroma, and (4) recruitment of bone marrow-derived cells from the circulation [2–5].”
BackgroundSlominski, A. T., Roloff, B., Zbytek, B., Wei, E. T., Fechner, K., Curry, J. L., & Wortsman, J. (2000) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2000)036<0201:ahsemt>2.0.co;2 · Cited by 56
Emura, M., Ochiai, A., Horino, M., Arndt, W., Kamino, K., & Hirohashi, S. (2000) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2000)036<0077:domfhb>2.0.co;2 · Cited by 51 · cited 1×
“. The ability of MSC to travel to solid tumors after intravenous administration and their ability to develop myofibroblast-like characteristics under defined culture conditions”
BackgroundMechanism of Regulation of HGF/SF Gene Expression in Fibroblasts by TGF-β1
Harrison, P., Bradley, L., & Bomford, A. B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2612 · Cited by 30
Inhibition of tumor–stromal interaction through HGF/Met signaling by valproic acid
Matsumoto, Y., Motoki, T., Kubota, S., Takigawa, M., Tsubouchi, H., & Gohda, E. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.089 · Cited by 28 · cited 2×
“The HGF/c-Met interaction plays a pivotal role in cancer invasion that is mediated by the tumor stromal cell production of HGF [52], which can induce ECM degradation, tubule formation and angiogenesis [53].”
BackgroundJiang, H., & Ren, J. (2008) · PubMed · Cited by 10
Research works printed but not linked: 1
- Studeny M Marini FC Zompetta C Champlin RE Filder IJ 2001 Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy. Blood 98
Cited by
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
“…factor-1 (SDF-1/CXCL12), and a variety of FGFs—with the capability to stimulate cancer cell proliferation (Cirri and Chiarugi, 2011; Erez et al., 2010; Franco et al., 2010; Kalluri and Zeisberg, 2006; Orimo et al., 2005; Rä sä nen and Vaheri, 2010; Rosen and MacDougald, 2006; Spaeth et al., 2009).”
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
“502 The possible mechanism is related to the spontaneous fusion between cancer cells and MSCs.”
BackgroundThe tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
“CAFs can derive from multiple resident precursors, such as endothelial cells, smooth muscle cells and myoepithelial cells, or mesenchymal stem cells (Brittan et al., 2002; Spaeth et al., 2009; Tomasek et al., 2002; Willis et al., 2006).”
BackgroundGuidelines for the welfare and use of animals in cancer research
An ad hoc committee of the National Cancer Research Institute, Workman, P., Aboagye, E. O., Balkwill, F., Balmain, A., Bruder, G., Chaplin, D. J., Double, J. A., Everitt, J., Farningham, D. A. H., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605642 · Cited by 1,442
“…angiogenic factors (Collado et al, 2007), cancer-associated fibroblasts (Noel et al, 1993; Orimo et al, 2005) or mesenchymal stem cells (Karnoub et al, 2007; Spaeth et al, 2009) can increase tumorigenicity, better recapitulate the human tumour microenvironment and enhance metastatic potential.”
Background
Metadata
- Authors
- Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Abigail Wexner Research Institute (US)
- Corresponding author
- Marini, Frank
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-04-07
- Volume
- 4
- Issue
- 4
- Pages
- e4992
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2661372
- OpenAlex
- W1979704965
- Cited by
- 807
- References
- 56
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 29 · 2023: 41 · 2022: 26 · 2021: 48 · 2020: 50 · 2019: 47 · 2018: 43 · 2017: 40 · 2016: 60 · 2015: 59 · 2014: 66 · 2013: 69 · 2012: 71
- FWCI
- 32.78
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-03-19)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense
- Susan G. Komen for the Cure
- National Cancer Institute (P50CA116199, CA-16672, CA-55164, R01CA109451, P01CA049639, 16672, P01CA055164, Ca-116199, RC1CA146381, BC083397, CA109451, P30CA016672, CA 49639)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- mesenchymal stem cells, cancer-associated fibroblasts, tumor progression, ovarian carcinoma, breast adenocarcinoma, pancreatic ductal adenocarcinoma, paracrine signaling, interleukin-6, microvascularization, tumor microenvironment, SKOV3 cells, xenograft models
- MeSH terms
- Animals, Cell Division, Female, Fibroblasts, Humans, Ovarian Neoplasms, Transplantation, Heterologous, Disease Progression, Cell Lineage, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.